Exploring the localised delivery of stromal depleting agents as a method for improving the delivery and efficacy of therapies for pancreatic ductal adenocarcinoma

Localised Delivery of Immunotherapy and Chemotherapy in Pancreatic Cancer Models Using a Polymeric Implant

Discovery and Clinical Utility of Novel Prognostic Biomarkers in Gastroesophageal Cancer

Targeting Misfolded SOD1 for Ubiquitin-Mediated Degradation as a Therapeutic Strategy for ALS

Coaxial hydrogel structures for drug delivery to tumors

Fabrication and Preclinical Assessment of Drug Eluting Wet Spun Fibres for Pancreatic Cancer Treatment

Development of Ligand-Directed Drug-Loaded Liposomes to Target Heterogeneous Tumour Cell Populations in Metastatic Breast Cancer

Molecular and clinical biomarkers in gastrointestinal cancer

Deciphering the role of serpinb2 in cancer invasion and metastasis

Development of Targeted Anticancer Agents using Novel N-Alkylisatin Derivatives

Advancing Microbial-Derived Therapies to Target Neutrophil-Pancreatic Cancer Crosstalk

Evaluation of Selective Urokinase Inhibition in Pancreatic Cancer: Insights into Drug Uptake and Lipid Metabolism via Mass Spectrometry Imaging